Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.86% | 5.62% | 3.02% | 1.94% | 2.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.86% | 5.62% | 3.02% | 1.94% | 2.52% |
| Cost of Revenue | 6.30% | 4.69% | 1.72% | 0.83% | 2.20% |
| Gross Profit | 10.36% | 7.14% | 5.15% | 3.74% | 3.05% |
| SG&A Expenses | 1.84% | -1.31% | -1.31% | -1.31% | -1.31% |
| Depreciation & Amortization | 3.64% | 3.09% | 3.57% | 3.64% | 4.07% |
| Other Operating Expenses | 16.72% | 13.57% | 12.06% | 10.94% | 13.45% |
| Total Operating Expenses | 8.13% | 6.20% | 3.71% | 2.83% | 4.29% |
| Operating Income | 6.34% | 2.36% | -0.71% | -2.71% | -6.46% |
| Income Before Tax | -10.19% | 10.16% | -6.23% | -10.19% | -12.74% |
| Income Tax Expenses | -7.50% | 6.94% | -10.22% | -14.12% | -17.33% |
| Earnings from Continuing Operations | -10.87% | 11.03% | -5.14% | -9.12% | -11.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 28.72% | -41.98% | -44.94% | -47.38% | -55.69% |
| Net Income | -7.11% | 6.32% | -11.37% | -15.77% | -18.88% |
| EBIT | 6.34% | 2.36% | -0.71% | -2.71% | -6.46% |
| EBITDA | 5.67% | 2.54% | 0.31% | -1.24% | -4.06% |
| EPS Basic | -1.21% | 14.87% | -2.49% | -6.47% | -9.78% |
| Normalized Basic EPS | 24.49% | -2.41% | -6.43% | -8.20% | -13.45% |
| EPS Diluted | -1.32% | 14.85% | -2.22% | -6.17% | -9.51% |
| Normalized Diluted EPS | 24.63% | -2.56% | -6.39% | -8.09% | -13.39% |
| Average Basic Shares Outstanding | -6.24% | -7.36% | -8.58% | -9.73% | -10.25% |
| Average Diluted Shares Outstanding | -6.21% | -7.32% | -8.71% | -9.92% | -10.37% |
| Dividend Per Share | 7.14% | 9.26% | 11.54% | 14.00% | 16.67% |
| Payout Ratio | 0.09% | -0.04% | 0.16% | 0.22% | 0.29% |